Stem Cell Banking
the future treatment of illnesses with stem cells
To be able to support the future treatment of illnesses with stem cells, it is advisable to store stem cells at a reliable Stem Cell Bank. Premium (Private) Stem Cell Banking and Public Stem Cell Banking under one roof are becoming the core competence of future success, linking stem cell banking Know how actively with potential therapeutic application.
Stem cell banking has been for more than 20 years available in the market. In the beginning, stem cells had been harvested from bone marrow to treat leukemia. Today we know that stem cells are available in almost all parts of our body. Stem cells can be collected from Embryonic and non-embryonic “Adult Stem Cells.” We are supporting the common adult stem cell activities of none Embryonic cells; this also avoids any unnecessary ethical discussion on R&D and treatment in this 21st-century science field.
Today stem cells can be harvested from many places of our body. Widespread is the collection of stem cells from bone marrow, placentas, umbilical cord tissue, and cord blood. More recently this had been expanded to adult stem cells from deciduous Baby teeth’s (Milk teeth’s), menstrual blood, adipose tissues (fat-Cells), peripheral blood, and even urine.
Stem cells can be easily harvested from the blood left in a baby’s umbilical cord, the cord tissue, or placenta after its birth, or via a mini-liposuction from adipose tissue (fat) or a specific bone marrow harvesting method.
The cord blood is then analyzed, stem cells are separated, processed and cryopreserved. Cryopreservation is the freezing in nitrogen where the growth process is halted for the stem cells until again unfrozen for future medical use.
The advantage of cryopreserving stem cells is that if they harvested at an early stage of life, it is believed that stem cell in an early stage of life has better regeneration capabilities. Stem cells, harvested today (2016) from adipose tissue and bone marrow, are already used in many stem cell clinics for investigational, autologous (own) stem cell therapy treatments without expansion. Expansion of stem cells, before re-injected into the human body has the advantage that their therapeutic effect, may increase due to the higher quantity of stem cell population in the body.
For an informative view on stem cell potential, we are using the video from American CryoStem on YouTube, describing the future of adult stem cells from adipose tissue, fat cells, from liposuction.
In the last years (2014), it became evident, that the collection of stem cells (mesenchymal stem cells) from adipose tissues may be generating 500 times larger quantities than usually obtained from bone marrow harvesting. This advantage appears to have changed in recent times due to new harvesting methods from bone marrow.
The collection of adult stem cells, from adipose tissue or bone marrow, can be performed much later in life as often the time to collect stem cells from the umbilical cord at the birth of a child or from baby teeth had not been performed.
Therefore, while healthy, besides the storage of stem cells from baby’s, Adult Stem Cell Banking may well become the “natural safety net” we can create to treat potential illnesses at a later time in life.
This “natural safety net” philosophy is certainly a valid option already with today’s Know how and information standard as Experimental Stem cell treatment becomes more and more available in some countries as a new medical alternative where other medication does not show the required result.
At this moment (November 2014), 2214 clinical studies are underway and registered at Clinical Trials.gov (Search mode: clinical trials – stem cell trials) to support the medical claims made in helping to improve the image of being a none proven, experimental treatment only.
Furthermore, stem cell treatment will advance as a “surgical medical procedure” with fresh, non-expanded autologous stem cells from bone marrow and adipose tissues (fat tissues) in a qualified out-patient clinic as a patient-funded experimental stem cell therapy. In 2016 it is estimated that more than 400 clinics globally are using non-expanded autologous stem cells for various investigational therapeutic treatments.
Many scientists and physicians believe, that the 21st century will be the century of Biological and Medical Revolution like the last century was for electronics, computers and communication devices. This trend is already proven by the nearly daily news flow – see our info bar on the right side – of advances in tissue engineering and stem cell technology. Unfortunately, some non-qualified clinics and physicians are creating a bad image, which is true, like shown in the somehow “constructed” report of “60 Minutes”……. (embedding, unfortunately, is disabled)
….. mentioning also, in that time, that mainstream medicine and some scientists are not yet believing that stem cells are a viable option for treatment of so far untreatable illnesses.
What is, however, at a certain time (The 60 minutes report is from 09. Jan. 2012!) correct, maybe tomorrow already outdated knowledge as scientific knowledge and qualified application is expanding exponentially and the more than 750 stem cell clinics in 2018, just 6 years later, demonstrate that Know how and its application is advancing rapidly.
Stem cell treatment with IRB approved protocols in qualified clinics with patient funded stem cell studies, being recorded, analyzed and published are certainly today in 2018, not falling into the “60 Minutes” treatment report category!
In our assessment, stem cell banking and the expansion of stem cells for therapeutic use will become more and more the interface between technological advances and applied therapeutic treatment, although regulators like the FDA and EMA try to defend their model of industrialized produced pharmaceutical also for stem cell and regenerative medicine treatments.
Japan has changed its regulatory environment already in 2013, and is since that time advancing its treatment potential with stem cells, becoming a true global leader of regenerative medicine.